ACHV
NASDAQ · Biotechnology
Achieve Life Sciences Inc
$6.30
-0.10 (-1.56%)
Open$6.47
Previous Close$6.40
Day High$6.61
Day Low$6.26
52W High$7.11
52W Low$2.02
Volume—
Avg Volume4.05M
Market Cap657.02M
P/E Ratio—
EPS$-1.11
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+406.2% upside
Current
$6.30
$6.30
Target
$31.89
$31.89
$22.93
$31.89 avg
$41.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 52.77B | 95.37B | 656.40M |
| Net Income | -130,725,724 | -212,638,987 | 10.36M |
| Profit Margin | -397.8% | -377.9% | 1.6% |
| EBITDA | -131,288,882 | -225,419,190 | 18.53M |
| Free Cash Flow | — | — | 6.70M |
| Rev Growth | -44.7% | -44.7% | +1.9% |
| Debt/Equity | 0.69 | 0.69 | 0.12 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $261.07 | +3.99% | 126.9 | 461.26B |
| AMGN | Amgen Inc | $374.15 | +3.55% | 25.9 | 201.93B |
| GILD | Gilead Sciences Inc | $131.27 | +4.21% | 17.7 | 162.98B |
| VRTX | Vertex Pharmaceuticals Inc | $528.04 | +6.03% | 30.4 | 131.79B |
| REGN | Regeneron Pharmaceuticals | $654.27 | +4.73% | 15.5 | 68.59B |
| ALNY | Alnylam Pharmaceuticals Inc | $312.78 | +3.68% | 72.4 | 41.76B |